PRL and hepatocellular carcinoma: Clinical prognostic curve analysis revealed that in the clinicopathological subgroups of age ≥ 65, male, female, and stage I-II, HCC samples with low PRL scores demonstrated better survival benefits (Supplementary Figs. 1B-1G).